Midi Health logo

Midi Health Review

7.0
★★★★☆3.5/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10

Best for: menopause-focused care with GLP-1 as a metabolic adjunct

Midi Health scores highest on state availability and ease of access.

Semaglutide

$164per 4 weeks

Tirzepatide

$209per 4 weeks

What the monthly price covers

Medication

Not stated

Provider visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform. GLP-1 prescribing is offered as a clinician-discretionary metabolic-health adjunct within the menopause care framework, not as a standalone weight-loss product. It accepts commercial insurance; Medicare is out of network (self-pay only), and Medicaid and Medi-Cal are not accepted.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideOral OptionAll 50 StatesInsurance CoordinationMenopause Specialty

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Midi Health logo
3.5 / 5
Our editorial rating
Visit Midi Health →

from $164/4 wks (billed per 4 weeks) · no insurance needed

Midi Health at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$164/4 wks (billed per 4 weeks)
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored Midi Health

Each dimension is scored algorithmically from Midi Health’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.8/10

At $164/mo (per 4 weeks), Midi Health runs about 8% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).

Effectiveness25%

7.7/10

Midi Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

6.7/10

Online intake and platform experience; 7 platform features disclosed.

Trust & Safety15%

6.5/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

8.1/10

Midi Health treats patients in all 50 states. Insurance pathways are offered for eligible patients.

Support10%

5.4/10

Midi Health provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
678providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Midi Health review

Last checked November 2026
  • Confirmed current pricing across 4 dose/plan tiers and 2 separate fees
  • Confirmed availability in all 50 states
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$164–$210/mo across 4 dose/plan tiers, plus 2 $150–$250/mo fees that exclude the medication (checked November 2026)
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Midi Health

We walked Midi Health’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Book a virtual visit through the registration portal.
  2. 2Meet with a clinician to discuss health history and symptoms.
  3. 3Receive a personalized care plan and prescriptions, including a GLP-1 plan when clinically appropriate.
Price shown only after intakeLive video visit required
  • Primarily a women's midlife/menopause telehealth service; the 'Personalized GLP-1 Plan' is one of several care options.
  • Insurance-based; accepted by major plans and available in all 50 states.
  • No upfront self-pay monthly price is displayed on the homepage.
  • A virtual visit with a clinician is required to receive a care plan and prescriptions.

GLP-1 medications Midi Health offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Self-pay initial visitFee — not a medication price
$250/mo

Per-visit self-pay fee, not a monthly medication price; GLP-1 medication is billed separately or through insurance. Compounded medication prices are published in the ladder rows below.

Self-pay continued care visitFee — not a medication price
$150/mo

Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.

GLP-1 injectable, starting doses (0.1–0.5 mg), 4-week supplyCompounded
$165.90per 4 weeks
semaglutide

Sold as a 4-week supply, so a year is 13 refills, not 12. Price rises with dose: $165.90 (0.1-0.5 mg) to $355.00 (2.5 mg). Shipping and supplies included, no membership fee.

Dual-action GLP-1/GIP injectable, starting doses (1.25–2.5 mg), 4-week supplyCompounded
$210per 4 weeks
tirzepatide

Sold as a 4-week supply (13 refills a year). Price rises with dose: $210.00 (1.25-2.5 mg) to $434.00 (13.75-15 mg). Shipping and supplies included.

GLP-1 sublingual, starting dose (0.075 mg), 4-week supplyCompounded · oral
$164per 4 weeks
semaglutide

Sold as a 4-week supply (13 refills a year). Price rises with dose: $164.00 (0.075 mg) to $275.00 (0.8 mg). Shipping and supplies included.

Dual-action GLP-1/GIP sublingual, starting dose (1 mg), 4-week supplyCompounded · oral
$209per 4 weeks
tirzepatide

Sold as a 4-week supply (13 refills a year). Price rises with dose: $209.00 (1 mg) to $460.00 (7 mg). Shipping and supplies included.

Ready to get started?

Plans and promotions change often, so check Midi Health's current pricing and active discounts before you decide.

See Midi Health pricing →

What we like

  • Available in all 50 states
  • Accepts commercial insurance, unlike cash-pay-only GLP-1 telehealth services
  • Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)
  • HSA and FSA funds can pay for visits and services

Watch-outs

  • Does not accept Medicaid or Medi-Cal; Medicare is out of network, so Medicare patients must self-pay and cannot submit claims
  • GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • Menopause-focused, so not the right fit for men or younger women whose main goal is weight loss
  • Medication is priced per 4-week supply, so a year of treatment is 13 refills, not 12

Midi Health is a menopause clinic that happens to prescribe GLP-1s, not a weight-loss shop

Midi Health is not a fast-lane, fill-out-a-form-and-get-a-shot GLP-1 service. Midi is a nationwide menopause and perimenopause telehealth platform, and GLP-1 medication (compounded semaglutide or tirzepatide, or a brand-name drug) shows up here as one tool inside a broader midlife-women's-health plan, usually alongside hormone therapy and other metabolic support. If you're a woman in your 40s or 50s whose weight gain, sleep, mood, and hot flashes all arrived together, that framing works in your favor. If your only goal is to lose weight as quickly and cheaply as possible, Midi is probably the wrong door to knock on.

How the pricing works: visit fees plus a separate medication bill

Most GLP-1 telehealth brands quote you a single all-in monthly number that bundles the drug and the visit. Midi does not work that way, and that catches people off guard. Midi publishes visit fees and a separate price list for its compounded medications. On the self-pay path you pay one fee for the initial visit and a lower fee for each continued-care visit, and the GLP-1 medication is billed separately on top of that. Compounded medication is sold as a 4-week supply, and the price rises with dose: compounded semaglutide injections run $165.90 to $355.00, and compounded tirzepatide injections run $210.00 to $434.00, with shipping and supplies included. Brand-name GLP-1s are sent to your pharmacy of choice, so their cost depends on that pharmacy and your insurance, and Midi publishes no brand-name price.

For context, a typical all-in GLP-1 telehealth plan runs around $179 a month. Midi's split structure (visit fees plus a 4-week medication price) makes a direct comparison harder. MadeMed is simpler to price, listing a single price at every dose on each product page. Your final number depends on whether you go through insurance or self-pay, and on the medication your clinician chooses. Go in expecting a visit fee plus a separate medication bill, not one tidy subscription price.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

Insurance is where Midi stands apart

Unlike the cash-pay-only crowd, Midi accepts commercial insurance. If your plan covers the visit, you pay only your standard copay and deductible for both the initial and follow-up appointments instead of the self-pay fees. For a lot of women that turns an expensive-looking service into a low-copay one, and it's a meaningful differentiator in a market where most GLP-1 startups won't touch insurance at all.

But read the fine print, because Midi is blunt about it: it does not accept Medicaid or Medi-Cal, and Medicare is out of network. The site says plainly that it cannot accept Medicaid or Medi-Cal patients at this time. Medicare beneficiaries can be seen as self-pay patients, but they cannot submit any claims for Midi visits, medications, or related services. If you're on Medicaid or Medi-Cal, Midi isn't an option, and if you're on Medicare, expect to pay the full self-pay rates.

What's prescribed, and how

  • Compounded [semaglutide](/drugs/semaglutide) and [tirzepatide](/drugs/tirzepatide) are both on Midi's price list, as injectables and as sublingual options.
  • Brand-name GLP-1s can be prescribed and sent to your pharmacy of choice, but Midi publishes no brand-name price.
  • The medication is dispensed separately from your visit, billed through your insurance or paid out of pocket, not bundled into the consult fee.
  • Prescribing is clinician-discretionary. A GLP-1 is offered when the clinician judges it appropriate inside your menopause and metabolic plan. It is not promised at intake.

That last point matters: you are not guaranteed a prescription when you sign up. Midi's clinicians decide whether a GLP-1 fits your overall midlife-health picture. That's clinically responsible, but if you arrive expecting an automatic yes, you may be disappointed.

Who should choose Midi, and who should walk

Midi is a strong fit for women navigating perimenopause or menopause who want one team handling hormones and metabolic health together, at the stage of life where GLP-1 efficacy and stubborn midlife weight regulation overlap most. The all-50-states coverage means it works regardless of where you live, and the insurance acceptance can make it surprisingly affordable if your plan plays along.

Skip it if you're a man, a younger woman whose sole focus is weight loss, anyone on Medicaid, or a Medicare patient who wants the visits covered. For a weight-loss-first program, PlexusDx's GLP-1 service says it has licensed providers in all 50 states. Skip it too if price transparency is your top priority. The visit-fee-plus-separate-medication model leaves uncertainty about your monthly total until a clinician sets your medication and dose. People who want a single, locked-in, all-in monthly price will find that frustrating here.

Trust, oversight, and what's missing

On the safety side, Midi reads well. There are no FDA warning letters on file for this provider, and the menopause-specialty framing means GLP-1s are layered into a supervised, whole-person care plan rather than handed out in isolation. The trade-off is a disclosure gap. Compounded prices are published, but brand-name costs depend on your pharmacy and insurance, and Midi names no compounding-pharmacy partner. The care model and state coverage are well documented. You can see how we weigh these factors in our scoring methodology.

Bottom line

Midi Health is the right call for midlife women who want menopause care and metabolic support (including a possible GLP-1) from one insurance-friendly, nationwide clinic, and who don't mind that the medication isn't guaranteed and is billed separately from the visits. It's the wrong call for pure weight-loss shoppers, anyone on Medicaid, Medicare patients who want coverage, and anyone who needs to know their exact monthly cost before they commit. Judge Midi as a menopause specialist that prescribes GLP-1s when warranted, not as a budget weight-loss service, and it's a solid, credentialed choice.

The Bottom Line

Midi Health scores highest on state availability and ease of access.

Score: 7/10Best for: menopause-focused care with GLP-1 as a metabolic adjunctFrom: $164/4 wks (billed per 4 weeks)

Ready to start with Midi Health?

From $164/4 wks (billed per 4 weeks). See current pricing and start your free consultation.

Midi Health might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Alternatives to Midi Health

7.7/ 10
Verified partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Verified partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Verified partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →

Head-to-head

Compare Midi Health vs…

Midi Health scores7.0/10

Side-by-side pricing, medications and scores. Pick a matchup.

All 46 Midi Health comparisons

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Midi Health is a nationwide telehealth platform focused on menopause and perimenopause care for women, available in all 50 states. It provides clinician-guided treatment plans that can include hormone therapy and, at the clinician's discretion, metabolic-health support. It is a menopause specialty practice rather than a general weight-loss provider.
GLP-1 prescribing at Midi is offered as a clinician-discretionary metabolic-health adjunct within a menopause care plan, not as a standalone weight-loss product. That means it is not guaranteed at intake; a licensed clinician determines whether a GLP-1 is appropriate for you as part of your overall care. Midi describes its weight management as personalized GLP-1 treatment integrated with menopause care.
Midi accepts commercial insurance and says it is in-network with most major plans, which is a differentiator versus cash-pay-only GLP-1 telehealth services. Medicare is out of network: Medicare beneficiaries can be seen as self-pay patients, but they cannot submit claims for Midi visits, medications, or related services. Midi does not accept Medicaid or Medi-Cal patients. HSA and FSA funds can be used for visits and services. Coverage for any specific medication still depends on your individual plan.
Under insurance, you pay your standard co-pay and deductible for visits. On a self-pay basis, Midi lists an initial visit at $250 and continued-care visits at $150; these are visit fees, and GLP-1 or other medication is billed separately or through insurance. Midi publishes compounded medication prices per 4-week supply, rising with dose: semaglutide injections from $165.90 to $355.00 and tirzepatide injections from $210.00 to $434.00, with shipping and supplies included. Midi also builds microdosing programs when clinically appropriate, with weekly doses from $34 for eligible patients. Brand-name GLP-1s go to your pharmacy of choice, so their cost depends on that pharmacy and your insurance.
Midi's homepage says it is available in all 50 states, though its GLP-1 programs page notes the program is not available in all 50 states, so confirm compounded GLP-1 availability for your state. Medicare is out of network everywhere: Medicare beneficiaries can be seen as self-pay patients but cannot submit claims. Midi does not accept Medicaid or Medi-Cal patients.
Midi is best suited to women in perimenopause or menopause who want integrated care where hormone and metabolic health overlap, rather than people whose sole goal is weight loss. It is generally not the right fit for men or younger patients seeking standalone GLP-1 access. A licensed clinician determines the appropriate treatment plan for you.
Midi Health doesn't use public promo or coupon codes. Third-party sites advertising "Midi Health discount codes" are typically fake; any current offer applies automatically through the link on this page.
Yes. Midi Health is a legitimate telehealth provider. Our editors independently verified its pricing and offering and scored it 7.0/10. As with any medication, consult a licensed clinician before starting.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Does not accept Medicaid or Medi-Cal; Medicare is out of network, so Medicare patients must self-pay and cannot submit claims; GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake; Menopause-focused, so not the right fit for men or younger women whose main goal is weight loss; Medication is priced per 4-week supply, so a year of treatment is 13 refills, not 12. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Midi Health review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Midi Health's current pricing

Plans from $164/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.